Abstract is: Sir Jonathan Stafford Nguyen-Van-Tam MBE FRCPath FRSB FMedSci (born 2 February 1964) is a British healthcare professional specialising in influenza, including its epidemiology, transmission, vaccinology, antiviral drugs and pandemic preparedness. After hospital work, he was involved variously as a university lecturer and within the pharmaceutical industry. Van-Tam became a Deputy Chief Medical Officer for England on 2 October 2017. He played a very significant part in the UK's response to the covid pandemic which started in 2020 as one of two deputies. He was due to step down at the end of March 2022 to take up an academic role.
| human | Q5 |
| P6200 | BBC News topic ID | c1ljm94qvldt |
| P1617 | BBC Things ID | 04f6888a-2e6d-40ab-9bb5-ffcc611d80a8 |
| P2671 | Google Knowledge Graph ID | /g/11c5s5tt4y |
| P269 | IdRef ID | 144612968 |
| P213 | ISNI | 0000000062416563 |
| P244 | Library of Congress authority ID | n2009182285 |
| P8189 | National Library of Israel J9U ID | 987007337715905171 |
| P1207 | NUKAT ID | n2013056196 |
| P496 | ORCID iD | 0000-0003-2579-4655 |
| P3368 | Prabook ID | 482835 |
| P1153 | Scopus author ID | 7003371567 |
| P4527 | UK Parliament thesaurus ID | 468789 |
| P214 | VIAF ID | 90464125 |
| P4789 | Who's Who UK ID | U293192 |
| P10832 | WorldCat Entities ID | E39PBJqBqcHt3q7PwDCfYGMgKd |
| P166 | award received | Knight Bachelor | Q833163 |
| Fellow of the Royal Society for Public Health | Q94516961 | ||
| Member of the Order of the British Empire | Q12201526 | ||
| Fellow of the Royal Society of Biology | Q28020499 | ||
| Fellow of the Royal College of Pathologists | Q30337212 | ||
| Fellow of the Faculty of Public Health | Q30458765 | ||
| P27 | country of citizenship | United Kingdom | Q145 |
| P69 | educated at | Boston Grammar School | Q4947925 |
| P108 | employer | University of Nottingham | Q472316 |
| P735 | given name | Jonathan | Q1158394 |
| Jonathan | Q1158394 | ||
| P511 | honorific prefix | Sir | Q209690 |
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| P6758 | supported sports team | Boston United F.C. | Q894605 |
| Q35558024 | "Late presenters" after paracetamol self poisoning |
| Q41001630 | A cluster-randomised controlled trial to test the efficacy of facemasks in preventing respiratory viral infection among Hajj pilgrims |
| Q28732472 | A new sentinel surveillance system for severe influenza in England shows a shift in age distribution of hospitalised cases in the post-pandemic period |
| Q90770528 | A novel framework for evaluating the impact of individual decision-making on public health outcomes and its potential application to study antiviral treatment collection during an influenza pandemic |
| Q30398254 | A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart. |
| Q92437555 | A rapid evidence appraisal of influenza vaccination in health workers: An important policy in an area of imperfect evidence |
| Q43789192 | Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates collected in the UK. |
| Q63865953 | Adolescents' desires and beliefs about motorcycling: implications for education |
| Q63865927 | Adverse medical events in British service personnel following anthrax vaccination |
| Q41842215 | Age is not only criterion for flu vaccine |
| Q43735742 | An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006. |
| Q30353936 | An evaluation of community assessment tools (CATs) in predicting use of clinical interventions and severe outcomes during the A(H1N1)pdm09 pandemic. |
| Q57094433 | Antiviral treatment for outpatient use during an influenza pandemic: a decision tree model of outcomes averted and cost-effectiveness |
| Q30210112 | Antivirals for influenza: where now for clinical practice and pandemic preparedness? |
| Q40899945 | Association between benzodiazepine use and exacerbations and mortality in patients with asthma: a matched case-control and survival analysis using the United Kingdom Clinical Practice Research Datalink |
| Q91622627 | Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink |
| Q30362048 | Avian influenza and the threat of the next human pandemic. |
| Q63865950 | BCG vaccine and leprosy |
| Q30371215 | Bacterial pneumonia and pandemic influenza planning. |
| Q30204612 | Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial 'in hibernation', ready for rapid activation |
| Q43924626 | Capecitabine monotherapy in metastatic colorectal cancer |
| Q30398779 | Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults |
| Q99602727 | Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study |
| Q33677531 | Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines. |
| Q54223806 | Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza. |
| Q41653933 | Cochrane column |
| Q38149671 | Cochrane re-arranged: support for policies to vaccinate elderly people against influenza |
| Q54649053 | Cohort Profile: The Flu Watch Study. |
| Q30361230 | Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. |
| Q28730789 | Comparison of CATs, CURB-65 and PMEWS as triage tools in pandemic influenza admissions to UK hospitals: case control analysis using retrospective data |
| Q91338268 | Corticosteroids as Adjunctive Therapy in the Treatment of Influenza: An Updated Cochrane Systematic Review and Meta-analysis |
| Q24186045 | Corticosteroids as adjunctive therapy in the treatment of influenza |
| Q24201063 | Corticosteroids as adjunctive therapy in the treatment of influenza |
| Q91861834 | Corticosteroids as adjunctive therapy in the treatment of influenza |
| Q63865922 | Costs of running a universal adolescent hepatitis B vaccination programme |
| Q96350276 | Cumulative incidence of post-infection asthma or wheezing among young children clinically diagnosed with respiratory syncytial virus infection in the United States: A retrospective database analysis |
| Q57093820 | Deposition of respiratory virus pathogens on frequently touched surfaces at airports |
| Q30224649 | Developing pandemic preparedness in Europe in the 21st century: experience, evolution and next steps |
| Q30380800 | Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study. |
| Q30224020 | Did pandemic preparedness aid the response to pandemic (H1N1) 2009? A qualitative analysis in seven countries within the WHO European Region |
| Q36729465 | Differences between asthmatics and nonasthmatics hospitalised with influenza A infection |
| Q63865898 | Disease Surveillance and Global Health Security |
| Q50652879 | Do influenza epidemics affect patterns of sickness absence among British hospital staff? |
| Q63865911 | Doctors accepting flu vaccination is the sensible and responsible choice |
| Q57105414 | Doncaster: the public health response to a local cluster of heterosexually acquired HIV infection |
| Q39458286 | Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination |
| Q30368753 | Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. |
| Q30365369 | Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK. |
| Q30235245 | Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis |
| Q30385275 | Effectiveness of common household cleaning agents in reducing the viability of human influenza A/H1N1. |
| Q90237311 | Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs |
| Q50972405 | Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. |
| Q30362392 | Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. |
| Q28082846 | Effectiveness of travel restrictions in the rapid containment of human influenza: a systematic review |
| Q41921626 | Effects of seasonal and pandemic influenza on health-related quality of life, work and school absence in England: results from the Flu Watch cohort study |
| Q63865914 | Epidemic and pandemic influenza |
| Q30396953 | Evaluation of inter-pandemic influenza vaccine effectiveness during eight consecutive winter seasons in England and Wales in patients with cardiovascular risk factors |
| Q41448147 | Evaluation of the 'Live Life Better Service', a community-based weight management service, for morbidly obese patients. |
| Q30401118 | Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage |
| Q56981885 | Excess hospital admissions for pneumonia and influenza in persons [gt-or-equal, slanted]65 years associated with influenza epidemics in three English health districts: 1987–95 |
| Q35559130 | Family doctor advice is the main determinant of pneumococcal vaccine uptake. |
| Q95603683 | Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol |
| Q95659598 | Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study |
| Q47562247 | Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study |
| Q30386492 | Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience |
| Q42016548 | General practice and accident and emergency department care: does the patient know best? |
| Q44805348 | Global assessment of resistance to neuraminidase inhibitors, 2008-2011: the Influenza Resistance Information Study (IRIS). |
| Q30353772 | Guidance on the use of respiratory and facial protection equipment. |
| Q63865940 | Health care experiences of Vietnamese families in Nottingham |
| Q28081489 | Healthcare workers' willingness to work during an influenza pandemic: a systematic review and meta-analysis |
| Q34291892 | Hidden impact of paramedic interventions |
| Q30397620 | Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial |
| Q30398645 | Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis |
| Q41497275 | Impact of infection control interventions on rates of Staphylococcus aureus bacteraemia in National Health Service acute hospitals, East Midlands, UK, using interrupted time-series analysis |
| Q30424329 | Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients |
| Q30381799 | Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis. |
| Q30381955 | Increased risk of A(H1N1)pdm09 influenza infection in UK pig industry workers compared to a general population cohort. |
| Q97684530 | Influenza A (H3) illness and viral aerosol shedding from symptomatic naturally infected and experimentally infected cases |
| Q30039767 | Influenza Vaccination Among Australian Hajj Pilgrims: Uptake, Attitudes, and Barriers |
| Q28394356 | Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic--the risk of aerosol generation during medical procedures |
| Q42580056 | Influenza and Other Respiratory Viruses. From the Editor's desk |
| Q63865906 | Influenza and other respiratory viral infections |
| Q44270946 | Influenza immunisation: policies and practices of general practitioners in England, 1991/92. |
| Q36503838 | Influenza immunization; vaccine offer, request and uptake in high-risk patients during the 1991/2 season |
| Q39425079 | Influenza in long-term care facilities |
| Q63865931 | Influenza outbreaks in elderly care institutions |
| Q63865933 | Influenza outbreaks in elderly care institutions |
| Q30357280 | Influenza vaccination coverage rates in the UK: a comparison of two monitoring methods during the 2002-2003 and 2003-2004 seasons. |
| Q34370991 | Influenza vaccination for immunocompromised patients: summary of a systematic review and meta-analysis. |
| Q26829551 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology |
| Q28740919 | Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective |
| Q40594760 | Influenza vaccines really work? Keeping apart the true from the false |
| Q63865954 | Interpandemic (seasonal) influenza |
| Q30428082 | Intervention strategies for emerging respiratory virus infections: policy and public health considerations |
| Q44531585 | Invasive meningococcal disease among university undergraduates: association with universities providing relatively large amounts of catered hall accommodation |
| Q30398597 | Is public transport a risk factor for acute respiratory infection? |
| Q30274816 | Middle East Respiratory Syndrome. |
| Q97557526 | Minimal transmission in an influenza A (H3N2) human challenge-transmission model within a controlled exposure environment |
| Q44693872 | Minimum dataset for confirmed human cases of influenza H5N1. |
| Q30426674 | Multi-centre observational study of transplacental transmission of influenza antibodies following vaccination with AS03(A)-adjuvanted H1N1 2009 vaccine |
| Q30373419 | Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study |
| Q95729248 | Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection |
| Q44149100 | Neuraminidase inhibitors for influenza complications--Authors' reply |
| Q30425347 | Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic |
| Q57105374 | Neuraminidase inhibitors were widely used in the UK during the 2009 influenza A(H1N1) pandemic |
| Q30371973 | Neuraminidase inhibitors: who, when, where? |
| Q30353075 | Non-pharmaceutical interventions for pandemic influenza, international measures. |
| Q63865946 | Non-steroidal anti-inflammatory drugs and appendicitis in patients aged over 50 years |
| Q30401581 | Nosocomial pandemic (H1N1) 2009, United Kingdom, 2009-2010 |
| Q30398196 | Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy. |
| Q95797642 | Oseltamivir resistance in influenza A (H5N1) infection |
| Q43220865 | Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. |
| Q40768569 | Outbreaks of influenza A in nursing homes in Sheffield during the 1997-1998 season: implications for diagnosis and control. |
| Q30391003 | Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. |
| Q63865901 | Pandemic preparedness and response |
| Q42653340 | Phylogenetic analysis of multiple heterosexual transmission events involving subtype b of HIV type 1. |
| Q30405341 | Potential role of human challenge studies for investigation of influenza transmission |
| Q51824985 | Practical prevention of nosocomial influenza transmission, 'a hierarchical control' issue. |
| Q40964370 | Practices and policies for influenza immunization in old people's homes in Nottingham (UK) during the 1992-1993 season: potential for improvement. |
| Q30402302 | Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease |
| Q56981524 | Pre-existing immunity in human challenge studies of influenza transmission – Authors' reply |
| Q63865891 | Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study |
| Q30414153 | Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. |
| Q43753114 | Preparing for a potential A(H7N9) pandemic: lessons from the deployment of A(H1N1) pandemic vaccines |
| Q51846214 | Principal author of PRIDE study responds to news story in The BMJ claiming that the study was based on "flawed" analysis. |
| Q36503354 | Protective efficacy of BCG vaccine against leprosy in southern Malaŵi. |
| Q63865917 | Public health responses to influenza in care homes: a questionnaire-based study of local Health Protection Units |
| Q42619265 | Public understanding of pandemic influenza, United Kingdom |
| Q39303371 | Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. |
| Q50595642 | Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. |
| Q40201065 | Reply to Jones et al. |
| Q54263533 | Reply: Letter to the editor, Cochrane rearranged. |
| Q40078684 | Responding to bird influenza: past, present and future |
| Q63865929 | Results of inguinal canal repair in athletes with sports hernia |
| Q24632365 | Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009) |
| Q26768419 | Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review |
| Q99247317 | Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score |
| Q30220472 | Routes of influenza transmission |
| Q94553636 | SARS-CoV-2 (COVID-19): What do we know about children? A systematic review |
| Q63865936 | Seven-week interval between acquisition of a meningococcus and the onset of invasive disease. A case report |
| Q57341509 | Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality |
| Q28742373 | Survival of influenza A(H1N1) on materials found in households: implications for infection control |
| Q38609970 | Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. |
| Q63865942 | Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery |
| Q59350799 | The Effect of Influenza Virus on the Human Oropharyngeal Microbiome |
| Q31100154 | The association between benzodiazepines and influenza-like illness-related pneumonia and mortality: a survival analysis using UK Primary Care data |
| Q34369010 | The comparative clinical course of pregnant and non-pregnant women hospitalised with influenza A(H1N1)pdm09 infection. |
| Q27001157 | The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis |
| Q40225897 | The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control |
| Q30332715 | The epidemiology and clinical impact of pandemic influenza. |
| Q42223415 | The first recorded outbreak of cryptosporidiosis due to Cryptosporidium cuniculus (formerly rabbit genotype), following a water quality incident |
| Q30383643 | The roles of transportation and transportation hubs in the propagation of influenza and coronaviruses: a systematic review. |
| Q63865920 | Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom |
| Q43172295 | Unmasking masks in Makkah: preventing influenza at Hajj |
| Q42586004 | Uptake of influenza vaccine. Epidemic of 1989-90 improved uptake |
| Q39680798 | Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. |
| Q30404708 | Use of antiviral drugs to reduce household transmission of pandemic (H1N1) 2009, United Kingdom |
| Q21559446 | Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies |
| Q36148015 | Vaccination of health care workers to protect patients at increased risk for acute respiratory disease |
| Q34371005 | Vaccination of healthcare workers to protect patients at increased risk of acute respiratory disease: summary of a systematic review. |
| Q63865945 | Vasectomy and prostate cancer: public health implications |
| Q43121244 | Vietnamese people in study may have had language difficulties |
| Q90325454 | Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS) |
| Q61045791 | What happens to medical students who complete an honours year in public health and epidemiology? |
| Q42764021 | Zanamivir for influenza: a public health perspective. Its use will require careful management by GPs. |
| Jonathan Van-Tam | wikipedia | |
| Jonathan Nguyễn Văn Tâm | wikipedia | |
| Jonathan Van-Tam | wikiquote |
Search more.